NIH director reportedly being tapped as acting CDC director
Source: SeekingAlpha
2026-02-18 14:13:52 ET
More on Pfizer, Johnson & Johnson, etc.
- Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game
- Pfizer: The Rebound Looks Unsustainable
- Merck: Keytruda Remains Resilient Despite LOE Risks - Buy Upon Correction
- J&J to build over $1B cell therapy production site in Pennsylvania
- AstraZeneca, Bristol partner with Evinova to use AI in drug development
Read the full article on Seeking Alpha
For further details see:
NIH director reportedly being tapped as acting CDC director
Novartis AG
NASDAQ: NVS
NVS Trading
-0.26% G/L:
$150.47 Last:
852,043 Volume:
$151.84 Open:
NVS Latest News
February 24, 2026 04:52:00 pm
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
NVS Stock Data
$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel
